Science

2021

  • Hong, NH. et al. Comprehensive preclinical characterization of the mechanism of action of EPI-7386, an androgen receptor N-terminal domain inhibitor. 2021 Prostate Cancer Foundation (PCF) Annual Scientific Retreat.

    Prostate Cancer Foundation 2021 Scientific Retreat Poster Presentation
  • Hong, NH. et al. Comprehensive preclinical characterization of the mechanism of action of EPI-7386, an androgen receptor N-terminal domain inhibitor. 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics. (Abstract: P192).

    AACR-NCI-EORTC 2021 Poster Presentation
  • . Comprehensive in vitro characterization of the mechanism of action of EPI-7386, an androgen receptor N-terminal inhibitor. 2021 AACR. (Abstract Number: 1209).

    AACR 2021 Poster Presentation
  • . Preclinical and clinical pharmacology of EPI-7386, an androgen receptor N-terminal domain inhibitor for castration-resistant prostate cancer. ASCO GU 2021. (Abstract Number: 119).

    ASCO-GU Poster Presentation

2020

  • . The preclinical characterization of the N-terminal domain androgen receptor inhibitor, EPI-7386, for the treatment of prostate cancer. ENA 2020 – 32nd Symposium. (EORTC-NCI-AACR) (Abstract ID #181).

    EORTC-NCI-AACR 32nd Symposium Poster